Literature DB >> 16107871

Characterization of the human CD5 endogenous retrovirus-E in B lymphocytes.

Y Renaudineau1, S Vallet, C Le Dantec, S Hillion, A Saraux, P Youinou.   

Abstract

All T lymphocytes and some B lymphocytes express CD5. This coreceptor is encoded by one gene that consists of 11 exons. We have previously described a B cell-specific alternative exon 1, leading to the synthesis of a protein, devoid of leader peptide, and, therefore, retained in the cytoplasm. The novel exon 1 originates from a human endogenous retrovirus (HERV) at a time interval between the divergence of New World monkeys from Old World monkeys, and prior to the divergence of humans from Old World monkeys. Based on sequence similarity to gamma-retroviruses, it was categorized as class I: based on the specificity of its primer binding site, it was allotted to the subclass E, and based on its location within the cd5 gene, named HERV-E.CD5. Alternative transcripts were detected in lymphoid organs including fetal liver (not adult liver), more particularly in CD5-negative cell surface B-1b than in CD5-positive cell surface B-1a, and not at all in B-2 cells. By alignment of 5' long terminal repeats, HERV-E.CD5 was distinguished from similar proviruses. This could be central to the regulation of membrane expression of CD5 in human B lymphocytes, and, thereby, to the strength of the B-cell antigen receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107871     DOI: 10.1038/sj.gene.6364253

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  11 in total

Review 1.  Autoreactive B cells and epigenetics.

Authors:  Yves Renaudineau; Soizic Garaud; Christelle Le Dantec; Ruby Alonso-Ramirez; Capucine Daridon; Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

2.  DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus.

Authors:  Tinhinane Fali; Christelle Le Dantec; Yosra Thabet; Sandrine Jousse; Catherine Hanrotel; Pierre Youinou; Wesley H Brooks; Andras Perl; Yves Renaudineau
Journal:  Autoimmunity       Date:  2013-10-14       Impact factor: 2.815

3.  Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents.

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Int J Clin Rheumtol       Date:  2011-08

4.  Immunophenotyping As a New Tool for Classification and Monitoring of Systemic Autoimmune Diseases.

Authors:  Yves Renaudineau
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

5.  Types of DNA methylation status of the interspersed repetitive sequences for LINE-1, Alu, HERV-E and HERV-K in the neutrophils from systemic lupus erythematosus patients and healthy controls.

Authors:  Patadon Sukapan; Paramate Promnarate; Yingyos Avihingsanon; Apiwat Mutirangura; Nattiya Hirankarn
Journal:  J Hum Genet       Date:  2014-01-16       Impact factor: 3.172

6.  Characterization of rabbit CD5 isoforms.

Authors:  Richard Pospisil; Juraj Kabat; Rose G Mage
Journal:  Mol Immunol       Date:  2009-06-10       Impact factor: 4.407

7.  Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases.

Authors:  Ruby Alonso-Ramirez; Séverine Loisel; Caroline Buors; Jacques-Olivier Pers; Enrique Montero; Pierre Youinou; Yves Renaudineau
Journal:  Arthritis       Date:  2011-02-10

Review 8.  The contribution of epigenetics in Sjögren's Syndrome.

Authors:  Orsia D Konsta; Yosra Thabet; Christelle Le Dantec; Wesley H Brooks; Athanasios G Tzioufas; Jacques-Olivier Pers; Yves Renaudineau
Journal:  Front Genet       Date:  2014-04-03       Impact factor: 4.599

Review 9.  Human endogenous retrovirus group E and its involvement in diseases.

Authors:  Christelle Le Dantec; Sophie Vallet; Wesley H Brooks; Yves Renaudineau
Journal:  Viruses       Date:  2015-03-16       Impact factor: 5.048

10.  EnHERV: Enrichment analysis of specific human endogenous retrovirus patterns and their neighboring genes.

Authors:  Pumipat Tongyoo; Yingyos Avihingsanon; Santhitham Prom-On; Apiwat Mutirangura; Wuttichai Mhuantong; Nattiya Hirankarn
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.